Dzierzanowska D, Jeljaszewicz J
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol. 1983 Sep;255(2-3):346-55.
Combined action in vitro and in vivo of ureidopenicillins (azlocillin and mezlocillin) with sisomicin has been studied with employment of strains of Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa. In vitro effects of these combinations were most spectacular with Pseudomonas aeruginosa; azlocillin and sisomicin were potently synergistic. Other tested microorganisms reacted also but less markedly. Evaluation of therapeutic efficacy of ureidopenicillins combined with sisomicin was performed on 90 rabbits, infected intravenously with heavy inocula. Synergistic action has been confirmed in vivo during treatment of infections evoked by Escherichia coli and Pseudomonas aeruginosa. Therapy of these infections may be successful with doses of azlocillin or mezlocillin combined with sisomicin diminished by half, as compared with treatment of these infections with above antibiotics applied singly. Further decrease of sisomicin dosage in combined therapy of P. aeruginosa infections with ureidopenicillin is possible.
利用大肠杆菌、肺炎克雷伯菌和铜绿假单胞菌菌株,研究了脲基青霉素(阿洛西林和美洛西林)与西索米星在体外和体内的联合作用。这些组合对铜绿假单胞菌的体外作用最为显著;阿洛西林和西索米星具有强大的协同作用。其他受试微生物也有反应,但不太明显。在90只静脉注射大量接种物而感染的兔子身上评估了脲基青霉素与西索米星联合治疗的疗效。在治疗由大肠杆菌和铜绿假单胞菌引起的感染过程中,体内协同作用得到了证实。与单独使用上述抗生素治疗这些感染相比,使用剂量减半的阿洛西林或美洛西林与西索米星联合治疗这些感染可能会取得成功。在脲基青霉素与铜绿假单胞菌感染的联合治疗中,进一步降低西索米星的剂量是可能的。